These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 8602705)

  • 21. Transitional cell carcinoma of the bladder associated with cyclophosphamide.
    Dale GA; Smith RB
    J Urol; 1974 Nov; 112(5):603-4. PubMed ID: 4214370
    [No Abstract]   [Full Text] [Related]  

  • 22. Urinary bladder cancer in Wegener's granulomatosis: risks and relation to cyclophosphamide.
    Knight A; Askling J; Granath F; Sparen P; Ekbom A
    Ann Rheum Dis; 2004 Oct; 63(10):1307-11. PubMed ID: 15130900
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Urinary bladder tumors following cyclophosphamide therapy: a report of two cases with a review of the literature.
    Samra Y; Hertz M; Lindner A
    Med Pediatr Oncol; 1985; 13(2):86-91. PubMed ID: 3982369
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hyperbaric oxygen therapy for Wegener's granulomatosis with cyclophosphamide-induced hemorrhagic cystitis.
    Kuroda I; Kuwata Y; Kakehi Y
    Int J Urol; 2002 Aug; 9(8):470-2. PubMed ID: 12225346
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of cyclophosphamide treatment on the epithelium and stroma of the urinary bladder.
    Beyer-Boon ME; de Voogt HJ; Schaberg A
    Eur J Cancer (1965); 1978 Oct; 14(10):1029-35. PubMed ID: 710474
    [No Abstract]   [Full Text] [Related]  

  • 26. [Cancer of the bladder after cystitis due to cyclophosphamide. Apropos of a case].
    Dore B; Grange P; Aubert J
    J Urol (Paris); 1989; 95(7):427-31. PubMed ID: 2687398
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hyperbaric oxygen therapy for control of intractable cyclophosphamide-induced hemorrhagic cystitis.
    Shameem IA; Shimabukuro T; Shirataki S; Yamamoto N; Maekawa T; Naito K
    Eur Urol; 1992; 22(3):263-4. PubMed ID: 1468485
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of mesna in preventing further cyclophosphamide-induced hemorrhagic cystitis.
    Luce JK; Simons JA
    Med Pediatr Oncol; 1988; 16(6):372-4. PubMed ID: 3143903
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Invasive bladder cancer after cyclophosphamide administration for nephrotic syndrome--a case report.
    Nakamoto T; Kasaoka Y; Ikegami Y; Usui T
    Hiroshima J Med Sci; 2000 Jun; 49(2):121-3. PubMed ID: 10920579
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence of Cyclophosphamide-induced Urotoxicity and Protective Effect of Mesna in Rheumatic Diseases.
    Yilmaz N; Emmungil H; Gucenmez S; Ozen G; Yildiz F; Balkarli A; Kimyon G; Coskun BN; Dogan I; Pamuk ON; Yasar S; Cetin GY; Yazici A; Ergulu Esmen S; Cagatay Y; Yilmaz S; Cefle A; Sayarlioglu M; Kasifoglu T; Karadag O; Pehlivan Y; Dalkilic E; Kisacik B; Cobankara V; Erken E; Direskeneli H; Aksu K; Yavuz S
    J Rheumatol; 2015 Sep; 42(9):1661-6. PubMed ID: 26178288
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adriamycin enhancement of cyclophosphamide-induced bladder injury.
    Ershler WB; Gilchrist KW; Citrin DL
    J Urol; 1980 Jan; 123(1):121-2. PubMed ID: 7351704
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Urological complications of cyclophosphamide.
    Levine LA; Richie JP
    J Urol; 1989 May; 141(5):1063-9. PubMed ID: 2651710
    [No Abstract]   [Full Text] [Related]  

  • 33. [A case of pulmonary metastases from bladder cancer, suspected of recurrent Wegener's granulomatosis].
    Sekiya M; Ichikawa M; Tsutsui A; Yoshimi K; Suzuki T; Seyama K; Uekusa T; Takahashi K
    Nihon Kokyuki Gakkai Zasshi; 2009 Oct; 47(10):943-6. PubMed ID: 19882920
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bladder cancer following administration of cyclophosphamide.
    Durkee C; Benson R
    Urology; 1980 Aug; 16(2):145-8. PubMed ID: 6250267
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carcinoma of the bladder complicating cyclophosphamide therapy.
    Ansell ID; Castro JE
    Br J Urol; 1975 Aug; 47(4):413-8. PubMed ID: 1180990
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cyclophosphamide hemorrhagic cystitis.
    Rubin JS; Rubin RT
    J Urol; 1966 Sep; 96(3):313-6. PubMed ID: 5953127
    [No Abstract]   [Full Text] [Related]  

  • 37. Treatment of cyclophosphamide-induced hemorrhagic cystitis with intravesical carboprost tromethamine.
    Levine LA; Jarrard DF
    J Urol; 1993 Apr; 149(4):719-23. PubMed ID: 8455230
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Uroepithelial carcinoma in association with cyclophosphamide ingestion.
    Fuchs EF; Kay R; Poole R; Barry JM; Pearse HD
    J Urol; 1981 Oct; 126(4):544-5. PubMed ID: 7288948
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclophosphamide-associated carcinoma of urothelium: modalities for prevention.
    Cannon J; Linke CA; Cos LR
    Urology; 1991 Nov; 38(5):413-6. PubMed ID: 1949449
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Urothelial cancers from Endoxan].
    Dumas JP; Roulet B; Colombeau P; Loubet R
    J Urol (Paris); 1984; 90(6):411-2. PubMed ID: 6520414
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.